Dr. Amanda Kong on High Versus Low Volume Hospitals in the Treatment of Breast Cancer

Video

​Amanda L. Kong, MD, MS, FACS, discusses breast cancer care at high volume hospitals versus low volume hospitals. Kong says the study is the first one that looks at processes as a bundle and takes into account socioeconomic statuses of patients.

Amanda L. Kong, MD, MS, FACS, associate professor, Medical College of Wisconsin, discusses breast cancer care at high volume hospitals versus low volume hospitals. Kong says the study is the first one that looks at processes as a bundle and takes into account socioeconomic statuses of patients. Kong adds that the study shows that high volume hospitals produce better survival rates than low volume hospitals.

The study gathered socioeconomic and sociodemographic information from women with breast cancer through a survey. In the future, Kong said she hopes to continue the study in a more contemporary group of patients, especially now that sentinel lymph node therapy has become the standard of care in breast cancer.

Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
Related Content